Search Results for "Scleroderma St Judes Cure"
Matching Channels
Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Dictionary). It...
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset. (Oxford Medical Dictionary). A seizure is caused by a sudden burst of ex...
Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...
Transforming growth factor beta TGF beta
Transforming growth factor-beta (TGF-beta) family members are secreted multifunctional cytokines that play pivotal roles in development and disease. The prototypic member of this family, TGF-beta, pla...
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference i...
Matching News
SAN FRANCISCO, May 16, 2013 /PRNewswire-USNewswire/ -- The nonprofit Scleroderma Research Foundation (SRF) will welcome Drs. Monique Hinchcliff, Lorinda Chung and Laura Hummers as featured speakers fo...
Siskin Rehabilitation Hospital Hosts Scleroderma Support Group
CHATTANOOGA, TN-- Siskin Hospital for Physical Rehabilitation announced Nov. 27 the addition of a new Support Group: the Chattanooga Scleroderma Support Group. According to the Scleroderma Foundat...
Scleroderma — Comprehensive overview covers symptoms and treatment of disorders that involve skin hardening.
A Free Service Provided by the Scleroderma Research Foundation with support from Gilead Sciences and MedImmune SAN FRANCISCO, Oct. 26, 2012 /PRNewswire-USNewswire/ -- The nonpr...
Scleroderma Foundation Announces New Heartland Chapter
Support for People in Nebraska, Iowa and Eastern South Dakota DANVERS, Mass., Sept. 28, 2012 /PRNewswire-USNewswire/ -- The Scleroderma Foundation announced today that it has chartered a new...
SAN FRANCISCO, Dec. 6, 2012 /PRNewswire-USNewswire/ -- The nonprofit Scleroderma Research Foundation (SRF) welcomes Andrew Tager, MD to present "New Directions for Scleroderma Treatments: Understandin...
New treatment target brings hope for scleroderma patients
Research presented at the European Academy of Dermatology and Venereology in Prague, Czech Republic, suggests that inhibition of the SMAD protein may be a viable therapeutic target in scleroderma pati...
Genes reveal which patients will benefit from scleroderma drug
(Northwestern University) The drug used to treat scleroderma is potentially toxic and doesn't work for everyone. New research shows gene expression signatures can accurately identify patients who will...
Matching PubMed Articles
Indirect immunofluorescence antinuclear antibodies (IIF-ANA) are detected in approximately 90% of scleroderma patients, and the staining pattern correlates with scleroderma-specific antibody subsets....
Scleroderma is a rare systemic autoimmune disease with multiple organ manifestations, including skin fibrosis. The groups of disorders classified as scleroderma mimics share the common thread of skin...
The importance of the genetic component in the pathogenesis of scleroderma, or systemic sclerosis, has been strengthened in the past 2 years with studies on genetic markers-either candidate gene or g...
Doppler indices of intrarenal arterial stiffness are useful in monitoring scleroderma renal crisis.
Localized Scleroderma Variants: Pharmacologic Implications.
Abstract Scleroderma, a complex syndrome, is a disease with varied, yet presumably related subtypes. We searched articles relating to localized scleroderma. By detailing these similarities and differe...
